These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30975390)

  • 61. Unravelling networks in local public health policymaking in three European countries - a systems analysis.
    Spitters HP; Lau CJ; Sandu P; Quanjel M; Dulf D; Glümer C; van Oers HA; van de Goor IA
    Health Res Policy Syst; 2017 Feb; 15(1):5. PubMed ID: 28159008
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A roadmap to parity in mental health financing: the case of Lebanon.
    Yehia F; Nahas Z; Saleh S
    J Ment Health Policy Econ; 2014 Sep; 17(3):131-41. PubMed ID: 25543116
    [TBL] [Abstract][Full Text] [Related]  

  • 63. CONTRIBUTION OF STAKEHOLDER ENGAGEMENT TO THE IMPACT OF A HEALTH TECHNOLOGY ASSESSMENT: AN IRISH CASE STUDY.
    Ryan M; Moran PS; Harrington P; Murphy L; O'Neill M; Whelan M; Teljeur C
    Int J Technol Assess Health Care; 2017 Jan; 33(4):424-429. PubMed ID: 29032786
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Partnerships for Policy Development: A Case Study From Uganda's Costed Implementation Plan for Family Planning.
    Lipsky AB; Gribble JN; Cahaelen L; Sharma S
    Glob Health Sci Pract; 2016 Jun; 4(2):284-99. PubMed ID: 27353621
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Critical factors that affect the functioning of a research and evaluation capacity building partnership: A causal loop diagram.
    Tobin R; Crawford G; Hallett J; Maycock BR; Lobo R
    PLoS One; 2022; 17(1):e0262125. PubMed ID: 35025924
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Evidence-based decision on medical technologies in Asia Pacific: experiences from India, Malaysia, Philippines, and Pakistan.
    Thatte U; Hussain S; de Rosas-Valera M; Malik MA
    Value Health; 2009; 12 Suppl 3():S18-25. PubMed ID: 20586975
    [TBL] [Abstract][Full Text] [Related]  

  • 67. New model for prioritised adoption and use of hospital medicine in Denmark since 2017: Challenges and perspectives.
    Wadmann S; Kjellberg J
    Health Policy; 2019 Jul; 123(7):606-610. PubMed ID: 31122758
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Disinvestments in practice: overcoming resistance to change through a sociotechnical approach with local stakeholders.
    Airoldi M
    J Health Polit Policy Law; 2013 Dec; 38(6):1149-71. PubMed ID: 23974471
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparative health systems. The Netherlands.
    van der Gaag J; Rutten FF; van de Ven WP
    Adv Health Econ Health Serv Res Suppl; 1990; 1():27-41. PubMed ID: 10113794
    [No Abstract]   [Full Text] [Related]  

  • 70. Rapid Assessment of Stakeholder Concerns about Public Health. An Introduction to a Fast and Inexpensive Approach Applied on Health Concerns about Intensive Animal Production Systems.
    Kraaij-Dirkzwager M; van der Ree J; Lebret E
    Int J Environ Res Public Health; 2017 Dec; 14(12):. PubMed ID: 29232902
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Current status of health technology reassessment of non-drug technologies: survey and key informant interviews.
    Leggett LE; Mackean G; Noseworthy TW; Sutherland L; Clement F
    Health Res Policy Syst; 2012 Dec; 10():38. PubMed ID: 23241276
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Developing a national medicines information strategy in Finland--a stakeholders' perspective on the strengths, challenges and opportunities in medicines information.
    Hämeen-Anttila K; Luhtanen S; Airaksinen M; Pohjanoksa-Mäntylä M
    Health Policy; 2013 Jul; 111(2):200-5. PubMed ID: 23683473
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A qualitative study assessing the acceptability and adoption of implementing a results based financing intervention to improve maternal and neonatal health in Malawi.
    Wilhelm DJ; Brenner S; Muula AS; De Allegri M
    BMC Health Serv Res; 2016 Aug; 16(1):398. PubMed ID: 27534528
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Community pharmacy minor ailment services: Pharmacy stakeholder perspectives on the factors affecting sustainability.
    Nazar H; Nazar Z
    Res Social Adm Pharm; 2019 Mar; 15(3):292-302. PubMed ID: 29778343
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Universal financial protection through National Health Insurance: a stakeholder analysis of the proposed one-time premium payment policy in Ghana.
    Abiiro GA; McIntyre D
    Health Policy Plan; 2013 May; 28(3):263-78. PubMed ID: 22791557
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Using stakeholder analysis to support moves towards universal coverage: lessons from the SHIELD project.
    Gilson L; Erasmus E; Borghi J; Macha J; Kamuzora P; Mtei G
    Health Policy Plan; 2012 Mar; 27 Suppl 1():i64-76. PubMed ID: 22388502
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The impact of the economic downturn on healthcare in Spain: consequences and alternatives.
    Antonanzas F
    Expert Rev Pharmacoecon Outcomes Res; 2013 Aug; 13(4):433-9. PubMed ID: 23977971
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Stakeholders' Views on Patient Access Schemes in Malaysia.
    Thanimalai S; Choon WY; Lee KK
    Value Health Reg Issues; 2022 Sep; 31():39-46. PubMed ID: 35398626
    [TBL] [Abstract][Full Text] [Related]  

  • 79. New trends and challenges in the European regulation of innovative medicines.
    Enzmann H
    Regul Toxicol Pharmacol; 2016 Oct; 80():314-20. PubMed ID: 27237379
    [TBL] [Abstract][Full Text] [Related]  

  • 80. ['Medical technology assessment'; more than just efficacy].
    Buskens E
    Ned Tijdschr Geneeskd; 2000 Mar; 144(13):622-6. PubMed ID: 10761552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.